Delivery Order SPE2DX22D0090-SPE2D826FAA0A

The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,826.20 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 1, 2025, with an ultimate completion date of October 2, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award supports the company's role as a critical pharmaceutical distributor and healthcare solutions provider, supplying the federal government with a comprehensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters.

This delivery order is executed under AmerisourceBergen's prime IDC with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's competitively awarded federal contracts consistently demonstrate the company's capability to fulfill diverse federal medical supply requirements through firm fixed-price delivery orders ranging from small transactions to substantial orders exceeding $45,000.